Based on the Nano X Imaging Ltd stock forecast from 3 analysts, the average analyst target price for Nano X Imaging Ltd is USD 14.25 over the next 12 months. Nano X Imaging Ltd’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Nano X Imaging Ltd is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Nano X Imaging Ltd’s stock price was USD 6.36. Nano X Imaging Ltd’s stock price has changed by +8.72% over the past week, +12.37% over the past month and +0.79% over the last year.
No recent analyst target price found for Nano X Imaging Ltd
No recent average analyst rating found for Nano X Imaging Ltd
Company Overview Nano X Imaging Ltd
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel. Read Less
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based o...Read More
Frequently Asked Questions About Nano X Imaging Ltd (NNOX) Stock
Based on ratings from 3 analysts Nano X Imaging Ltd's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and hold ratings.
Unfortunately we do not have enough data on NNOX's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for NNOX is USD 14.25 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 12.
Unfortunately we do not have enough data on NNOX's stock to indicate if its overvalued.
The last closing price of NNOX's stock was USD 6.36.
The most recent market capitalization for NNOX is USD 0.37B.
Based on targets from 3 analysts, the average taret price for NNOX is projected at USD 14.25 over the next 12 months.
This means that NNOX's stock price may go up by +124.06% over the next 12 months.
We can't find any ETFs which contains Nano X Imaging Ltd's stock.
As per our most recent records Nano X Imaging Ltd has 164 Employees.
Nano X Imaging Ltd's registered address is 94 Shlomo Shmeltzer Road, Petah Tikva, Israel, 4970602.
You can get more information about it from Nano X Imaging Ltd's website at https://www.nanox.vision.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Nano X Imaging Ltd (NNOX) Stock
Based on ratings from 3 analysts Nano X Imaging Ltd's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 4 buy, sell and hold ratings.
Unfortunately we do not have enough data on NNOX's stock to indicate if its a good dividend stock.
Based on targets from 3 analysts, the average taret price for NNOX is USD 14.25 over the next 12 months. The maximum analyst target price is USD 17 while the minimum anlayst target price is USD 12.
Unfortunately we do not have enough data on NNOX's stock to indicate if its overvalued.
The last closing price of NNOX's stock was USD 6.36.
The most recent market capitalization for NNOX is USD 0.37B.
Based on targets from 3 analysts, the average taret price for NNOX is projected at USD 14.25 over the next 12 months.
This means that NNOX's stock price may go up by +124.06% over the next 12 months.
We can't find any ETFs which contains Nano X Imaging Ltd's stock.
As per our most recent records Nano X Imaging Ltd has 164 Employees.
Nano X Imaging Ltd's registered address is 94 Shlomo Shmeltzer Road, Petah Tikva, Israel, 4970602.
You can get more information about it from Nano X Imaging Ltd's website at https://www.nanox.vision.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for NNOX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
